This study highlights the importance of heart rate recovery (HRR) in cardiovascular assessments and the need for standardized evaluation protocols, especially in heart failure, to improve diagnostics and patient care.

Addressing low BP in HF patients is complex, requiring individualized treatment strategies based on patient conditions, comorbidities, and HF etiology, as a one-size-fits-all approach is ineffective.

The massive loss of cardiomyocytes after cardiac injury and their subsequent replacement by fibrotic tissue is the major cause of heart failure, while the cardiomyocytes have limited proliferative capacity. Therefore, inducing resident cardiomyocytes to re-enter the cell cycle and progress through mitosis and cytokinesis is the most...

To regulate immune responses in heart failure (HF) through blocking the proinflammatory cytokine TNF-α failed despite promising preclinical data and success in autoimmune diseases. Recent discoveries, such as the production of the cytokine Oncostatin M in HF patients, which makes them unresponsive to anti-TNF-α treatment, highlight the need...

Single-cell technology has allowed researchers to probe tissue complexity and dynamics at unprecedented depth in health and disease. However, the generation of high-dimensionality single-cell atlases and virtual three-dimensional tissues requires integrated reference maps that harmonize disparate experimental designs, analytical pipelines,...

In our cohort, loop diuretic discontinuation was possible and safe in a large proportion of patients. The results should be interpreted with caution and cannot be extrapolated to a broader population of HF patients.

These findings provide insight into the shared pathobiology of heart failure and frailty in late life and suggest potential molecular pathways that can be targeted by interventions to mitigate the burden of both conditions.

The overall picture of the study encourages the use of DAPA in the primary prevention of cardiomyopathies induced by anthracyclines in patients with cancer.

In summary, this study underscores that, despite the influence of biologic therapy on certain markers, standard allergy tests remain viable while emphasizing the importance of considering specific IgE levels rather than relying solely on CAP classes. The Skin Prick Test in particular proves to be a reliable tool for identifying sensitizations...

Lipoprotein(a), a genetic risk factor for CAVD, augments calcification via several mechanisms, wherein hydrolysis of oxidized phospholipids (oxPLs) by Lp(a)-associated enzymes helps generate orthophosphate, and apolipoprotein(a) blocks plasmin-induced fibril degradation. Current studies of amyloid-calcium-collagen interactions in solution and...

Patients living with HIV infection had a higher risk of all-cause mortality, major adverse CV events, recurrent acute coronary syndromes, and admission for HF after the index event, despite being approximately 11 years younger at the time of the event.

Catheter ablation of atrial fibrillation compared with conventional medical therapies was associated with reduced risk of HF events in patients with reduced ejection fraction.

Physiology-guided complete revascularization effectively improved outcomes and decreased complication rate, irrespective of high bleeding risk status.

Ventricular tachycardia or ventricular fibrillation occurring ≥1 days after primary PCI and associated with cardiac arrest was rare, occurring in 0.4% of all patients and 0.1% of patients with uncomplicated STEMI.

In obesity-related HF with preserved ejection fraction, semaglutide was effective in multiple domains, regardless of baseline diuretic use/dose, and let to a significant reduction in loop diuretic use over time.

The greatest reversals were seen in those aged <45 and 45-64 years, men, Non-Hispanic Black individuals, and those living in rural areas, the South, and the Midwest.

Fractional flow reserve–guided complete revascularization was not shown to result in a lower risk of a composite of death from any cause, MI, or unplanned revascularization than culprit-lesion-only PCI at 4.8 years.

Beta blockers did not lead to a lower cumulative incidence of the secondary endpoints (death from any cause, death from CV causes, MI, hospitalization for atrial fibrillation, and hospitalization for HF).

The clinical outcomes of these patients who received optimized medical therapy alone were poor, with a 1-year composite of cardiac death or heart failure readmission of 47.4%.